1.Biomechanical Comparison of Different Repair Methods for Inferior Pole Fracture of the Patella
Yulin XU ; Yuangui TANG ; Yongkang CUI ; Yuchuan LIU ; Tao WANG ; Wanyin QI ; Jinhui LIU ; Cheng LIANG
Journal of Medical Biomechanics 2025;40(1):100-105
Objective To conduct a comparative study on the biomechanical performance of using sutures for repairing inferior pole patellar fractures.Methods Compared to the normal patellar structure(Group A),four repair methods,namely,'Krackow'suture(Group B),"Kessler"fixation(Group C),'8-figure'mesh method(Group D),and modified suture bridge(Group E)were adopted.The static stiffness and dynamic stability of inferior pole patellar fractures fixed by each repair method were measured at 30°,60°,and 90° knee flexion.Results The stiffness at all flexion angles in Group E was closer to that in Group A,compared to other repair groups,followed by Group B,then Group D,and finally Group C.After the first cycle,at 30° knee flexion,Group C showed the greatest displacement,while Groups B and E had slightly larger displacements than the Group A,and the displacement of Group D was smaller than that of Group A.At 60° and 90° knee flexion,the displacement in all repair groups was smaller than that of Group A.After 200 cycles in the subsequent three cycles,displacement changes in all repair groups were smaller than those in Group A.Conclusions All repair methods were effective.In terms of biomechanical fixation performance,the modified suture bridge was superior to the'Krackow'suture and'8-figure'mesh,with Kessler fixation being the least effective.However,factors such as the injury severity,incision location,and surgical time should be comprehensively considered in actual clinical use,and it is recommended that the repair method should be selected in the following order:E,B,D,and C.
2.Biomechanical Comparison of Different Repair Methods for Inferior Pole Fracture of the Patella
Yulin XU ; Yuangui TANG ; Yongkang CUI ; Yuchuan LIU ; Tao WANG ; Wanyin QI ; Jinhui LIU ; Cheng LIANG
Journal of Medical Biomechanics 2025;40(1):100-105
Objective To conduct a comparative study on the biomechanical performance of using sutures for repairing inferior pole patellar fractures.Methods Compared to the normal patellar structure(Group A),four repair methods,namely,'Krackow'suture(Group B),"Kessler"fixation(Group C),'8-figure'mesh method(Group D),and modified suture bridge(Group E)were adopted.The static stiffness and dynamic stability of inferior pole patellar fractures fixed by each repair method were measured at 30°,60°,and 90° knee flexion.Results The stiffness at all flexion angles in Group E was closer to that in Group A,compared to other repair groups,followed by Group B,then Group D,and finally Group C.After the first cycle,at 30° knee flexion,Group C showed the greatest displacement,while Groups B and E had slightly larger displacements than the Group A,and the displacement of Group D was smaller than that of Group A.At 60° and 90° knee flexion,the displacement in all repair groups was smaller than that of Group A.After 200 cycles in the subsequent three cycles,displacement changes in all repair groups were smaller than those in Group A.Conclusions All repair methods were effective.In terms of biomechanical fixation performance,the modified suture bridge was superior to the'Krackow'suture and'8-figure'mesh,with Kessler fixation being the least effective.However,factors such as the injury severity,incision location,and surgical time should be comprehensively considered in actual clinical use,and it is recommended that the repair method should be selected in the following order:E,B,D,and C.
3.Cases analysis of liver injury associated with Qubai Babuqi tablets(驱白巴布期片)
Zhengwei YANG ; Yuanyuan ZHOU ; Yi TANG ; Feilin GE ; Yuming GUO ; Hu Huang WANYIN ; Chuanduo SUN ; Jiabo WANG
Adverse Drug Reactions Journal 2019;21(3):198-202
Objective To explore the clinical characteristics and influencing factors of liver injury associated with Qubai Babuqi tablets.Methods Case reports of liver injury associated with Qubai Babuqi tablets in the National Adverse Drug Reaction Monitoring System (ADRMS) from 2012 to 2016 and clinical information of patients with liver injury induced by Qubai Babuqi tablets,who were admitted to the Fifth Medical Center of PLA General Hospital from 2008 to 2017,were collected and retrospectively analyzed.Results A total of 64 patients (59 from case reports in ADRMS and 5 from the Fifth Medical Center of PLA General Hospital) with liver injury induced by Qubai Babuqi tablets were enrolled,including 32 males and 32 females,aged from 10 to 73 years with an average age of (34 ± 13) years.Thirty-three patients (51.6%) were treated with Qubai Babuqi tablets alone,31 patients (48.4%) had combined medication,and 3 of the 64 patients suffered from liver injury again after their remedication of Qubai Babuqi tablets.The median time from medication to liver injury was 33 (2-210) days and the median cumulative dose of Qubai Babuqi tablets was 184.5 (8.0-868.5) g.There were 35 patients (54.7%) with severe liver injury.No significant association was found between the severity of liver injury and the dose of the drug (P > 0.05).But the proportion of patients with severe liver injury treated with combined medication was significantly higher than that of patients with severe liver injury treated with Qubai Babuqi tablets alone [67.7% (21/31) vs.42.4% (14/33),x2 =4.282,P =0.042].Among the 64 patients,the liver injury was cured in 31 patients,improved in 21 patients,did not improve in 2 patients,worsened in 2 patients (developed to hepatic encephalopathy and cirrhosis,respectively),and had unknown outcomes in 8 patients.Conclusions About half of the liver injuries caused by Qubai Babuqi tablets were severe ones.The prognosis of liver injury was relatively good and it could be cured or improved in most patients.The combination of other drugs might be the influencing factor of severe liver injury caused by Qubai Babuqi tablets.
4.Clinical characteristics of patients with dengue fever accompanied by platelet count reduction and analysis of their traditional Chinese medicine syndrome and treatment
Xiaolan QIN ; Yuntao LIU ; Jiechao ZHENG ; Yuemin ZHANG ; Wanyin TANG ; Zhongde ZHANG
Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care 2019;26(4):429-432
Objective To analyze the clinical features of patients with dengue fever (DF) accompanied by platelet count (PLT) reduction and their characteristics of traditional Chinese medicine (TCM) syndrome differentiation and treatment. Methods The clinical data of 1 570 patients with confirmed diagnosis of DF collected from the Information Management System (HIS) of the Second Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine (TCM) from January 2013 to December 2017 were retrospective analyzed. According to the patients accompanied by platelet (PLT) reduction or not, they were divided into DF accompanied by PLT reduction group (1 211 cases) and non-PLT reduction group (359 cases); according to whether the cooling blood and dissipating blood stasis TCM (composed of red peony, peony bark, rehmannia root, salvia miltiorrhiza, rhinoceros horn, etc.) was used or not in TCM syndrome differentiation prescription, they were divided into cooling blood and dissipating blood stasis group (492 cases) and non-cooling blood and dissipating blood stasis group (719 cases). The differences in clinical characteristics, laboratory indicators, TCM syndrome differentiation and prescription characteristics in DF accompanied by PLT reduction group and non-PLT reduction group were compared and analyzed; the differences in changes of white cell counts (WBC) and PLT levels before and after treatment between cooling blood and dissipating blood stasis group and non-cooling blood and dissipate blood stasis group were compared and analyzed. Results The proportions of rash, hemorrhage, WBC reduction and aspartate transaminase (AST) elevation in DF accompanied by PLT reduction group were significantly higher than those in non-PLT reduction group [rash: 61.4% (744/1 211) vs. 14.8% (53/359), hemorrhage: 7.3% (89/1 211) vs. 1.1% (4/359), WBC reduction: 88.2% (1 068/1 211) vs. 60.4% (217/359), AST increased: 41.0% (497/1 211) vs. 29.5% (106/359)]; the PLT and WBC in the DF accompanied by PLT reduction group were significantly lower than those in the non-PLT reduction group [PLT (×109/L): 74.2±27.5 vs. 166.6±42.8, WBC (×109/L): 2.1±1.6 vs. 6.4±3.7, both P < 0.05], and AST in the DF accompanied by PLT reduction group were significantly higher than those in the non-PLT reduction group (U/L: 69.6±34.1 vs. 52.6±26.1, P < 0.05). The common syndrome of TCM syndrome differentiation in DF accompanied by PLT reduction group and non-PLT reduction group was mainly Wei-Qi syndrome [425 cases (35.1%) and 147 cases (40.9%) respectively]; Yinqiao powder was the main TCM prescription in the two groups [132 cases (10.9%) and 46 cases (12.8%) respectively]. In the comparisons between the cooling blood and dissipate blood stasis group and non-cooling blood and dissipate blood stasis group, there were no statistically significant differences in the proportion of combining use of drugs for increasing WBC and PLT and the levels of WBC and PLT after treatment (all P > 0.05). After treatment, the WBC, PLT levels and the proportions of above indexes returned to normal in the cooling blood and dissipate blood stasis group were significantly higher than those in the non- cooling blood and dissipate blood stasis group [WBC(×109/L): 4.5±3.1 vs. 3.2±2.4, proportion of WBC returned to normal: 42.7% (210/492) vs. 33.1% (238/719); PLT (×109/L): 85.9±26.2 vs. 79.3±24.8, proportion of PLT returned to normal: 41.1% (202/492) vs. 27.5% (198/719), all P < 0.05]. Conclusions The symptoms of skin rash and bleeding are more common in patients with DF accompanied by PLT reduction. The syndrome differentiation of TCM for this disease is mostly based on the combined disorders of Wei (defence) and Qi, both Qi and blood burning and blood stasis associated with toxin. Cooling blood and dissipating blood stasis may help the recovery of WBC and PLT in these patients, which is of great significance in reducing severity of dengue fever (such as bleeding).
5.Cases analysis of liver injury associated with Qubai Babuqi tablets(驱白巴布期片)
Zhengwei YANG ; Yuanyuan ZHOU ; Yi TANG ; Feilin GE ; Yuming GUO ; Hu Huang WANYIN ; Chuanduo SUN ; Jiabo WANG
Adverse Drug Reactions Journal 2019;21(3):198-202
Objective To explore the clinical characteristics and influencing factors of liver injury associated with Qubai Babuqi tablets.Methods Case reports of liver injury associated with Qubai Babuqi tablets in the National Adverse Drug Reaction Monitoring System (ADRMS) from 2012 to 2016 and clinical information of patients with liver injury induced by Qubai Babuqi tablets,who were admitted to the Fifth Medical Center of PLA General Hospital from 2008 to 2017,were collected and retrospectively analyzed.Results A total of 64 patients (59 from case reports in ADRMS and 5 from the Fifth Medical Center of PLA General Hospital) with liver injury induced by Qubai Babuqi tablets were enrolled,including 32 males and 32 females,aged from 10 to 73 years with an average age of (34 ± 13) years.Thirty-three patients (51.6%) were treated with Qubai Babuqi tablets alone,31 patients (48.4%) had combined medication,and 3 of the 64 patients suffered from liver injury again after their remedication of Qubai Babuqi tablets.The median time from medication to liver injury was 33 (2-210) days and the median cumulative dose of Qubai Babuqi tablets was 184.5 (8.0-868.5) g.There were 35 patients (54.7%) with severe liver injury.No significant association was found between the severity of liver injury and the dose of the drug (P > 0.05).But the proportion of patients with severe liver injury treated with combined medication was significantly higher than that of patients with severe liver injury treated with Qubai Babuqi tablets alone [67.7% (21/31) vs.42.4% (14/33),x2 =4.282,P =0.042].Among the 64 patients,the liver injury was cured in 31 patients,improved in 21 patients,did not improve in 2 patients,worsened in 2 patients (developed to hepatic encephalopathy and cirrhosis,respectively),and had unknown outcomes in 8 patients.Conclusions About half of the liver injuries caused by Qubai Babuqi tablets were severe ones.The prognosis of liver injury was relatively good and it could be cured or improved in most patients.The combination of other drugs might be the influencing factor of severe liver injury caused by Qubai Babuqi tablets.

Result Analysis
Print
Save
E-mail